Andreas Wilm, Director of Computational Biology and Lorenz Gerber, Associate Director of Software Engineering at ImmunoScape contributed a blog post for Amazon Web Services (AWS) to share how we were able to build an agile drug discovery pipeline with scalable compute...
One of our senior scientists in discovery, Juliana Barclay, will be presenting at Society for Immunotherapy of Cancer (SITC) 2022 in Boston this Friday, November 11. Juliana will present on the discovery and development of t-cell receptors for adoptive T-cell therapy...
ImmunoScape’s CEO Choon-Peng Ng is featured in Endpoints. Endpoints highlights ImmunoScape’s $14M funding round, our use of machine learning to discover TCR-T cell therapies focused on solid tumors, and our progress toward the clinic. You can read the full...
